Company page

Nfl Biosciences Sa

Nfl Biosciences SA is a public company listed on the French market under the ticker ALNFL, with a market capitalization of approximately €12.13 million. The company focuses on developing innovative bioscience solutions. Nfl Biosciences is committed to advancing its research and product offerings in the biosciences sector.

profileALNFL:EURONEXTAI content: aiUpdated June 24, 2026/company/nfl-biosciences-sa/c-l53shkir
Nfl Biosciences Sa logo
Ticker
ALNFL:EURONEXT
Asset type
Stock
Market cap
$12.1M
Sector
Health Technology
Industry
Biotechnology
Exchange
EURONEXT
Currency
EUR